WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin
The Hindu
A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
The World Health Organisation (WHO) said “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its . The latest guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”. A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said. According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.More Related News
Prosecutor says Trump tried 'to hoodwink voters' while defence attacks key witness in last arguments
Prosecutors accuse Trump of conspiracy in hush money trial, defense calls star witness "greatest liar of all time."